Efficacy and Safety of Rosuvastatin in the Prevention of Arterial and Venous Vascular Events and Mortality After Hip Fracture: A Multicenter Randomised, Double-blinded, Placebo Controlled Trial.
Phase of Trial: Phase III
Latest Information Update: 19 Sep 2012
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism
- Focus Therapeutic Use
- Acronyms STAFF
- 01 Sep 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov record.
- 06 Apr 2012 Planned End Date changed from 1 Mar 2014 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 06 Apr 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.